The agency is
not required to display the expiration date.
Inventory as of this Action
Requested
Previously Approved
01/31/2003
01/31/2003
04/30/2000
100
0
100
836
0
965
0
0
0
Filers use this form to elect to claim
the orphan drug credit, which is 50 percent of the qualified
clinical testing expenses paid or incurred with respect to low or
unprofitable drugs for rare diseases and conditions, as designated
under section 526 of the Federal Food, Drug, and Cosmetic
Act.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.